PAR-21-159: Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2021.
National Institutes of Health offered grants of up to $2.0 million to nonprofits and colleges and universities. Applications closed on May 4, 2021.
From the official notice on Grants.gov, last changed May 4, 2021. Checked November 7, 2026.
- Award ceiling$2.0 million
- Cost sharingRequired
- Funding typeGrant
About this NIH notice
- Activity codeC06
- Clinical trialsNot allowed
Application due dates, page limits and budget limits are set in the notice. Read PAR-21-159 in the NIH Guide.
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| PAR-21-238 | May 4, 2021 | Closed January 6, 2022 | Closed |
Key dates
| Posted | April 12, 2021 |
|---|---|
| Deadline | May 4, 2021 |
| Archived by Grants.gov | June 3, 2021 |
Who can apply
This opportunity was open to nonprofits and colleges and universities.
- Public and State controlled institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See FOA for full eligibility details.
Is this a realistic fit?
- Past Construction Support awards averaged $6.7 million; this notice allows up to $2.0 million per award.
- Most of the program's money (80% over five years) went to colleges and universities.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
This Funding Opportunity Announcement (FOA) invites applications from qualified research institutions to seek funds to develop or renovate research facilities that support HIV/AIDS research in areas of basic, translational, clinical, and social and behavioral science research. Targeted are institutions that serve underrepresented and underserved populations or that are in Institutional Development Award (IDeA)-eligible states. Research-intensive institutions are not eligible. The facilities must support research aligned with the NIH-established priorities for HIV/AIDS research. Any request must be justified by current and anticipated future research needs.
Who has won Construction Support grants before
From fiscal 2021 to 2025, Construction Support (93.352) awarded $350 million across 52 grant awards, an average of $6.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The University of Iowa | Iowa | 2 | $11.4 million |
| University of Wisconsin System | Wisconsin | 1 | $8.0 million |
| University of Kansas Medical Center Research Institute, Inc. | Kansas | 1 | $8.0 million |
| Weill Medical College of Cornell University | New York | 1 | $8.0 million |
| Ohio University | Ohio | 1 | $8.0 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-21-159 still open?
No. It closed on May 4, 2021.
Who can apply for Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from nonprofits and colleges and universities. The notice adds further conditions, so read its eligibility section.
What is the deadline for Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)?
Closed May 4, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $2.0 million each.
Who has won Construction Support grants before?
The largest recipients over five fiscal years were The University of Iowa, University of Wisconsin System, University of Kansas Medical Center Research Institute, Inc. The program made 52 awards worth $350 million in that time.
Similar open grants
- Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)